Aims: To investigate self-reports of memory and health as predictors of transition to mild cognitive impairment (MCI) or any mild cognitive disorder (any MCD) in a community-based study. Method: 2,082 individuals, aged 60–64 years, were assessed at 2 time points 4 years apart for MCI using either the International Consensus Criteria, the Clinical Dementia Rating scale (CDR, 0.5), or a suite of criteria sets for mild cognitive disorders (any MCD) and global cognitive change. Logistic and multiple regression was used to assess conversion to diagnosis and cognitive change from the SF-12 self-rated health (SRH) and physical health subscale measures, as well as reports of memory problems. Results: Of the 2,082 participants with no cognitive impairment at wave 1, 18 participants had a diagnosis of MCI, 32 a CDR score of 0.5, and 64 participants presented with any MCD 4 years later. After controlling for age, sex and education, SRH and physical health were significant predictors of MCD, memory interference was the only significant predictor of MCI, and cognitive change was associated with SRH, physical health and memory interference. Conclusion: Brief, short, easily collected self-reports of health, disability and memory can provide useful information on the risk of MCD and cognitive decline in young-old adults.

1.
Ravaglia G, Forti P, Maioli F, et al: Conversion of mild cognitive impairment to dementia: predictive role of mild impairment subtypes and vascular risk factors. Dement Geriatr Cogn Disord 2006;21:51–58.
2.
Amieva H, Letenneur L, Dartigues JF, et al: Annual rate and predictors of conversion to dementia in subjects presenting mild cognitive impairment criteria defined according to a population-based study. Dement Geriatr Cogn Disord 2004;18:87–93.
3.
Ashford JW: APOE genotype effects on Alzheimer’s disease onset and epidemiology. J Mol Neurosci 2004;23:157–165.
4.
Skoog T, Gustafen D: Update on hyptertension and Alzheimer’s disease. Neurol Res 2006;28:605–611.
5.
Craft S: Insulin resistance and Alzheimer’s disease pathogenesis: potential mechanisms and implications for treatment. Curr Alzheimer Res 2007;4:147–152.
6.
Eggermont I, Swaab D, Luiten P, Scherder F: Exercise, cognition and Alzheimer’s disease: more is not necessarily better. Neurosci Biobehav Rev 2006;30:562–575.
7.
Anstey KJ, von Sanden C, Salim AO, O’Kearney R: Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol 2007;166:367–378.
8.
O’Keefe JH, Bybee KA, Lavie CJ: Alcohol and cardiovascular health: the razor-sharp double edged sword. J Am Coll Cardiol 2007;50:1009–1014.
9.
Cherbuin N, Reglade-Meslin C, Kumar R, et al: Risk factors of transition from normal cognition to mild cognitive disorder: the PATH through Life Study. Dement Geriatr Cogn Disord 2009;28:47–55.
10.
Knopman D, Boland LL, Mosley T, et al: Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001;56:42–48.
11.
Tervo S, Kivipelto M, Hanninen T, et al: Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects. Dement Geriatr Cogn Disord 2004;17:196–203.
12.
WHO: Physical status: the use and interpretation of anthropometry. Report of a WHO expert committee. WHO Technical Report Series. Geneva, World Health Organisation, 1995, report No. 854.
13.
Franks P, Gold MR, Fiscella K: Sociodemographics, self-rated health, and mortality in the US. Soc Sci Med 2003;56:2505–2514.
14.
Ostbye T, Krause KM, Norton MC, et al: Ten dimensions of health and their relationships with overall self-reported health and survival in a predominately religiously active elderly population: the cache county memory study. J Am Geriatr Soc 2006;54:199–209.
15.
Emmelin M, Weinehall L, Stegmayr B, Dahlgren L, Stenlund H, Wall S: Self-rated ill-health strengthens the effect of biomedical risk factors in predicting stroke, especially for men – an incident case referent study. J Hypertens 2003;21:887–896.
16.
Ben-Ezra M, Shmotkin D: Predictors of mortality in the old-old in Israel: the Cross-Sectional and Longitudinal Aging Study. J Am Geriatr Soc 2006;54:906–911.
17.
De Salvo KB, Bloser N, Reynolds K, He J, Muntner P: Mortality prediction with a single general self-rated question: a meta-analysis. J Gen Intern Med 2006;20:267–275.
18.
De Salvo KB, Fan VS, McDonell MB, Fihn SD: Predicting mortality and healthcare utilization with a single question. Health Serv Res 2005;40:1234–1246.
19.
Finlayson M: Changes predicting long-term care use among the oldest-old. Gerontologist 2002;42:443–453.
20.
Bond J, Dickinson HO, Matthews F, Jagger C, Brayne C: Self-rated health status as a predictor of death, functional and cognitive impairment: a longitudinal cohort study. Am J Public Health 2006;3:193–206.
21.
Scott WK, Macera CA, Cornman CB, Sharpe PA: Functional health status as a predictor of mortality in men and women over 65. J Clin Epidemiol 1997;50:291–296.
22.
Stuck AE, Walthert JM, Nikolaus T, Bula CJ, Hohmann C, Beck JC: Risk factors for functional status decline in community-living elderly people: a systematic literature review. Soc Sci Med 1999;48:445–469.
23.
Schofield PW, Marder K, Dooneief G, Jacobs DM, Sano M, Stern Y: Association of subjective memory complaints with subsequent cognitive decline in community-dwelling elderly individuals with baseline cognitive impairment. Am J Psychiatry 1997;154:609–615.
24.
Peterson RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303–308.
25.
Crook T, Bartus R, Ferris SH, Whitehouse P, Cohen G, Gershon S: Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change. Report of a National Institute of Mental Health Working Group. Dev Neuropsychol 1986;2:261–276.
26.
World Health Organisation: The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva, World Health Organisation, 1992.
27.
Van der Flier WM, Pijnenburg YA, Schoonenboom SN, Dik MG, Blankenstein MA, Scheltens P: Distribution of APOE genotypes in a memory clinic cohort. Dement Geriatr Cogn Disord 2008;25:433–438.
28.
Reid LM, MacLullich AMj: Subjective memory complaints and cognitive impairment in older people. Dement Geriatr Cogn Disord 2006;22:471–485.
29.
Anstey KJ, Cherbuin N, Christensen H, et al: Follow-up of mild cognitive impairment and related disorders over 4 years in adults in their sixties: the PATH through Life Study. Dement Geriatr Cogn Disord 2008;26:226–233.
30.
Kumar R, Dear KB, Christensen H, et al: Prevalence of mild cognitive impairment in 60- to 64-year-old community-dwelling individuals: the Personality and Total Health through Life 60+ Study. Dement Geriatr Cogn Disord 2005;19:67–74.
31.
Morris JC: The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;11:2412–2414.
32.
Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303–308.
33.
Kral VA: Senescent forgetfulness: benign and malignant. Can Med Assoc J 1962;86:257–260.
34.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington, APA, 1994.
35.
Morris JC: The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412–2414.
36.
Ware JE, Kosinski M, Keller SD: A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220–223.
37.
Spitzer RL, Kroenke K, Williams JBW: Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA 1999;282:1737–1744.
38.
Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M: Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption. Addiction 1993;88:791–804.
39.
Maddox GL, Douglas EB: Self-assessment of health: a longitudinal study of elderly subjects. J Health Soc Behav 1973;14:87–93.
40.
Pinquart M: Correlates of subjective health in older adults: a meta-analysis. Psychol Aging 2001;16:414–426.
41.
Sargent-Cox KA, Anstey KJ, Luszcz MA: Determinants of self-rated health items with different points of reference: implications for health measurement of older adults. J Aging Health 2008;20:739–761.
42.
Elfgren C, Gustafson L, Vestberg S, Passant U: Subjective memory complaints, neuropsychological performance and psychiatric variables in memory clinic attendees: a 3-year follow-up study. Arch Gerontol Geriatr 2010;51:e110–e114.
43.
Mitchell AJ: The clinical significance of subjective memory complaints in the diagnosis of mild cognitive impairment and dementia: a meta-analysis. Int J Geriatr Psychiatry 2008;23:1191–1202.
44.
Saliba D, Elliott M, Rubenstein LZ, et al: The vulnerable elders survey: a tool for identifying vulnerable people in the community. J Am Gerontol Soc 2001;49:1691–1699.
45.
Sargent-Cox KA, Anstey KJ, Luszcz MA: Patterns of longitudinal change in older adults’ self-rated health: the effect of the point of reference. Health Psychol 2010;29:143–152.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.